학술논문
Rituximab in rheumatology: single-centre SARSCoV-2 infection and COVID-19 prevalence
Letter to the Editor (Other)
Letter to the Editor (Other)
Document Type
Letter to the editor
Author
Source
Rheumatology Advances in Practice. January 2022, Vol. 6 Issue 1
Subject
Language
English
ISSN
2514-1775
Abstract
Dear Editor, Observational registry data have been published to date suggesting an increased risk of severe coronavirus disease 2019 (COVID-19) in rheumatic disease patients treated with rituximab [1-4]. Evaluation of [...]